Avalyn Pharma Inc. · NASDAQ:AVLN

Rhodes Melissa sold 13,300 Avalyn Pharma Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Rhodes Melissa (Chief Operating Officer) sold 13,300 Avalyn Pharma Inc. shares at an average US$27.90 for US$371K under a trading plan, leaving 0 shares. Filed Nov 19, 2026 (Form 4).

Sold
13,300 shares
Price
US$27.90 average (US$27.79 to US$29.23)
Value
US$371K
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockOption exercise13,300US$4.6213,300Direct
Nov 17, 2026Common StockSale10,875US$27.792,425Direct
Nov 17, 2026Common StockSale2,025US$28.21400Direct
Nov 17, 2026Common StockSale400US$29.230Direct

Source

Download original · View original at SEC

Related